Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001764013-21-000104
Filing Date
2021-10-05
Accepted
2021-10-05 12:04:03
Documents
2
Period of Report
2021-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163344982778382.html 3  
1 FORM 3 wf-form3_163344982778382.xml 3 1724
2 POWER OF ATTORNEY EVA RENEE BARNETT ex-24.htm EX-24 4342
  Complete submission text file 0001764013-21-000104.txt   7548
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOVANT, INC. 320 WEST 37TH STREET, 6TH FLOOR NEW YORK NY 10018
Business Address
Barnett Eva Renee (Reporting) CIK: 0001883766 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 211305639